financetom
Business
financetom
/
Business
/
Scilex Approves Dividend of Semnur Shares to Stockholders
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scilex Approves Dividend of Semnur Shares to Stockholders
May 22, 2026 11:27 AM

01:59 PM EDT, 05/22/2026 (MT Newswires) -- Scilex Holding ( SCLX ) said Friday its board approved a dividend of Semnur Pharmaceuticals' common stock held by the company to its stockholders and certain eligible equity holders.

The record date for the dividend is June 1, and the board will set the payment date within 60 days of that date.

Holders as of the record date will receive one Semnur common share for each Scilex ( SCLX ) common share held, or for each share issuable upon exercise or conversion of eligible securities.

Scilex ( SCLX ) said it holds 186 million Semnur shares and plans to distribute about 10.7 million under the approved ratio.

The board may change the record date or revoke the dividend before payment if solvency or surplus conditions change, the company said.

Scilex's ( SCLX ) Semnur stake dates back to a 2019 corporate transaction.

Price: 6.07, Change: +0.15, Percent Change: +2.45

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Keros Therapeutics Hindered by KER-065 Concerns Despite 'Intriguing' Pipeline, BofA Says
Keros Therapeutics Hindered by KER-065 Concerns Despite 'Intriguing' Pipeline, BofA Says
Jun 10, 2025
12:11 PM EDT, 06/10/2025 (MT Newswires) -- Keros Therapeutics' ( KROS ) near-term upside remains limited due to uncertainty surrounding the development of its lead drug candidate, KER-065, despite an intriguing pipeline and strong cash position, BofA Securities said Monday in a report. Following a review, Keros plans to return $375 million in excess capital to shareholders and move ahead...
What's Going On With Oklo Stock Tuesday?
What's Going On With Oklo Stock Tuesday?
Jun 10, 2025
Oklo Inc ( OKLO ) shares are trending again on Tuesday with shares up nearly 65% over the past month. The company provided an update on regulatory progress. What Happened: Oklo ( OKLO ) on Tuesday announced that the U.S. Nuclear Regulatory Commission (NRC) initiated a review of the company’s licensed operator topical report as Oklo ( OKLO ) continues...
Update: Cineplex May Box Office Revenue Rises to $55.3 Million
Update: Cineplex May Box Office Revenue Rises to $55.3 Million
Jun 10, 2025
12:09 PM EDT, 06/10/2025 (MT Newswires) -- (Adds analyst comment and updates shares.) Cineplex ( CPXGF ) on Tuesday reported box office revenues of $55.33 million for May. The cinema operator's box office revenue for the month rose 63% from $33.94 million in May, 2024. A company statement noted that the film Lilo & Stitch set a new record for...
Copyright 2023-2026 - www.financetom.com All Rights Reserved